Brown Advisory’s Oragenics OGEN Stock Holding History

Brown Advisory’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3	Closed	-$23K	–	1145
2016 Q3	$23K	Hold	3	–	–	﹤0.01%	1064
2016 Q2	$25K	Buy	+3	New	+$40.2K	﹤0.01%	1038

Other funds holding OGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brown Advisory's OGEN Position: Q4 2016 in Review

Brown Advisory sold out of Oragenics (OGEN) in Q4 2016, closing a stake of 3 shares — an estimated $23K sold.

Brown Advisory first reported a position in OGEN in Q2 2016 and held it in 2 quarters. The position peaked at $25K in Q2 2016. 13 funds tracked by Wall St. Rank hold OGEN as of Q4 2016.

Brown Advisory reported no remaining Oragenics position as of Q4 2016 after selling out during the quarter.
Brown Advisory sold 3 Oragenics shares in Q4 2016, an estimated $23K.
Brown Advisory first reported a position in Oragenics in Q2 2016 and held it in 2 quarters.
Brown Advisory's Oragenics position peaked at $25K in Q2 2016.
13 funds tracked by Wall St. Rank held Oragenics as of Q4 2016.

Based on Brown Advisory's 13F filing for Q4 2016, filed 13 Feb 2017.